Corient Private Wealth’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
208,837
+104,708
+101% +$656K ﹤0.01% 1696
2026
Q1
$630K Buy
104,129
+80,655
+344% +$472K ﹤0.01% 1907
2025
Q4
$150K Buy
23,474
+473
+2% +$3.36K ﹤0.01% 2476
2025
Q3
$174K Buy
+23,001
New +$168K ﹤0.01% 2371
2024
Q4
Sell
-25,175
Closed -$102K 2407
2024
Q3
$102K Hold
25,175
﹤0.01% 2327
2024
Q2
$64.2K Hold
25,175
﹤0.01% 2242
2024
Q1
$112K Hold
25,175
﹤0.01% 2174
2023
Q4
$119K Hold
25,175
﹤0.01% 2143
2023
Q3
$122K Buy
+25,175
New +$155K ﹤0.01% 1998

Other funds holding EVLV

Corient Private Wealth's EVLV Position: Q2 2026 in Review

Corient Private Wealth increased its Evolv Technologies (EVLV) stake by 101% in Q2 2026, buying an estimated $656K and bringing the position to 208,837 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Corient Private Wealth first reported a position in EVLV in Q3 2023 and has held it in 9 quarters since. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Corient Private Wealth held 208,837 shares of Evolv Technologies worth $1.21M as of Q2 2026.
  • Corient Private Wealth bought 104,708 Evolv Technologies shares in Q2 2026, an estimated $656K.
  • Evolv Technologies made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1696 holding.
  • Corient Private Wealth first reported a position in Evolv Technologies in Q3 2023 and has held it in 9 quarters since.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.